MIS416 Multiple Sclerosis Trial Results MStranslate June 28, 2017 MIS416, Research, Treatments On Tuesday, Innate Immunotherapeutics released a report outlining the first set of results from their Phase 2b trial on the use of their compound, MIS416, in people with secondary progressive multiple...
Multiple Sclerosis Treatment Overview: AHSCT MStranslate June 13, 2017 Stem Cells, Treatments 1 Comment Recently, I’ve had the pleasure of talking to a number of different local multiple sclerosis support groups about multiple sclerosis (MS) and MS research. These events generally involve me giving a small...
Health Impacts of Interferon-beta Use in MS MStranslate May 16, 2017 Interferon-beta, Research, Treatments Research Summary: Evaluating the safety of β-interferons in MS Research from the University of British Columbia has looked at the long-term health effects of interferon-beta treatment in people with...
Secondary Progressive Multiple Sclerosis & Statins MStranslate May 15, 2017 Research, Treatments There has been a lot of media attention recently on a trial testing statins as a treatment for multiple sclerosis (MS). The study is being led by University College London and will involve over 1100 people...
Multiple Sclerosis Treatment Information: Daclizumab MStranslate May 3, 2017 Daclizumab, Treatments It has been reported this week that daclizumab (marketed as Zinbryta) has been added to the Pharmaceutical Benefits Scheme (PBS) in Australia. Considering this, we thought it appropriate to provide some more...
Mitochondrial Dysfunction & ER Stress in MS MStranslate April 4, 2017 Research, Treatments Research Summary: Rab32 connects ER stress to mitochondrial defects in multiple sclerosis Mitochondria are often referred to as the ‘powerhouses’ of the cell, as they are largely responsible for the...
US FDA Approves Ocrelizumab (Ocrevus) MStranslate March 30, 2017 Ocrelizumab, Treatments Ocrelizumab (Ocrevus) has been granted US FDA approval for the treatment of both replacing-remitting MS (RRMS) and primary progressive MS (PPMS). Ocrelizumab is a monoclonal antibody that targets and...
Apitope Announce Positive Peptide Therapy Results MStranslate February 28, 2017 Research, Treatments Imagine you have a dog and a cat and they keep fighting. Solution 1: give one of your pets to someone else. Solution 2: Teach them to get along. Solution 1 describes almost all current MS...
HALT-MS: Five Year Study Results MStranslate February 2, 2017 Research, Stem Cells, Treatments Research Summary: High dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS The 5 year results of the HALT-MS trial were today published in Neurology. The HALT-MS clinical trial has...
Case Studies Reveal New Alemtuzumab Side-effects MStranslate January 26, 2017 Alemtuzumab, Research, Treatments Research Summary: Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy A recent report in Lancet Neurology has highlighted two case studies of severe side effects in people with MS receiving...